# Hematopoietic Stem Cell Transplant in Devic's Disease

> **NCT00787722** · PHASE1,PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 13 (actual)

## Conditions studied

- Devic's Disease

## Interventions

- **PROCEDURE:** Hematopoietic Stem Cell Transplantation
- **DRUG:** Cyclophosphamide
- **DRUG:** G-CSF
- **DRUG:** rATG
- **DRUG:** Mesna
- **DRUG:** Rituximab
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT00787722
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-10
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2020-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787722, "Hematopoietic Stem Cell Transplant in Devic's Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00787722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*